Journal of International Oncology

Journal of International Oncology ›› 2012, Vol. 39 ›› Issue (3): 200-202.

Previous Articles     Next Articles

Epidermal growth factor receptor Ⅲ variant and targeted therapy of glioblastoma

YAN  Hong-Lian, ZHANG  Long-Zhen   

  1. Institute of Graduate, Xuzhou Medical College, Xuzhou 221002, China
  • Online:2012-03-08 Published:2012-02-24
  • Contact: ZHANG Long-zhen,E-mail: jsxzzlz@126.com E-mail:jsxzzlz@126.com

PDF

2197

Abstract: Epidermal growth factor receptor Ⅲ variant (EGFRvⅢ) is high expressed in gliomas, which can be used as a target to treat cancer. The therapy methods of glioblastoma targeted for EGFRvⅢ include RNA interference, immunotherapy, etc.

Key words: color: green, font-family: "Times New Roman", mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-fareast-font-family: 宋体, mso-no-proof: yes">Receptor, epidermal growth factor, color: green, font-family: "Times New Roman", mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-fareast-font-family: 宋体, mso-no-proof: yes">Glioma, color: green, font-family: "Times New Roman", mso-ansi-language: EN-US, mso-fareast-language: ZH-CN, mso-bidi-language: AR-SA, mso-fareast-font-family: 宋体, mso-no-proof: yes">Molecular targeted therapy